About Us
- Home
- / About Us
Who We Are
Delivering a safer future.
At VeriChem, we are dedicated to providing law enforcement and forensic professionals with cutting-edge solutions for the accurate identification of illicit substances and precise analysis. Our focus is on enhancing safety, efficiency, and making a positive societal impact.
Our Vision
We envision a world where forensic science seamlessly integrates with advanced technology, ensuring safer communities and swifter justice. As pioneers in our field, we strive to set global standards, drive meaningful innovations, and pave the way for a future where technology and human expertise converge to solve the most intricate challenges of our time.
01
Innovative
VeriChem thrives at the forefront of technological advancements, consistently pushing boundaries to develop groundbreaking solutions in forensic science.
02
Pioneering
Leading the charge in integrating future technology into solutions, we're setting new benchmarks and charting unexplored territories in illicit drug detection.
03
Precision-focused
Every tool and solution we engineer prioritizes accuracy, ensuring that forensic professionals are equipped with the most reliable data for crucial decision-making.
04
Transformative
Beyond mere enhancements, our technologies aim to revolutionize the entire forensic landscape, driving a paradigm shift in how investigations and analyses are approached.
Our Areas of Focus
Creating solutions that solve forensic challenges.
VeriChem stands at the forefront of forensic innovation redefining illicit drug identification. Drawing from esteemed academic partnerships, we’re poised to address the escalating challenges in the booming forensic market. Our commitment transcends technology, aiming to effect profound societal change and enhance safety on all fronts.
The MagLev device was developed in the Whitesides research group at Harvard University
Whitesides Research Group at Harvard University
Today one of the world’s most influential chemists, Whitesides, the Woodford L. and Ann A. Flowers University Research Professor, has worked on a wide array of scientific problems, shifting focus periodically to uncharted territory. Over the course of his long career — Harvard College, Caltech, MIT, and more than four decades as a researcher and teacher back at Harvard — he’s explored nuclear magnetic spectroscopy, organometallic chemistry, molecular self-assembly, soft robotics, unconventional data storage, microfabrication, nanotechnology, and the origin of life. He has published more than 1,200 scientific articles and holds more than 100 patents, and his many honors include the National Medal of Science. He’s also known for his ability to spin discoveries into new companies, including biotech giant Genzyme, purchased in 2011 by Sanofi.
